[Possibility to shorten the treatment of the newly detected patients with tuberculosis through continuous and intermittent application of rifampicin, myambutol and isoniasid (author's transl)].
D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin
Mogućnosti skraćenja lecenja novootkrivenih tuberkuloznih bolesnika kontinuiranom i intermitentnom terapijom, rifampicinom, myambutolom i izonijazidom